Observational studyRevista medica del Instituto Mexicano del Seguro Social2024
Surgical management of pelvic tumors through hemipelvectomy
Observational study in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary malignant bone tumors are rare however, have a high global mortality rate. Osteosarcoma and chondrosarcoma are the most common bone sarcomas in the pelvis. The surgical management of primary bone tumors in the pelvis is challenging and depends on several factors. Internal hemipelvectomy with extremity preservation has become more popular compared to external hemipelectomy. Objective: Identify and describe characteristics of the surgical management of bone tumors and soft tissues of the pelvis by means of hemipelvectomy. Material and methods: Observational study of consecutive cases, in which patients with bone and soft tissue tumors undergoing hemipelvectomy were identified from January 2010 to December 2020 at the Oncology Surgery Department, using the Musculoskeletal Tumor Society (MSTS) scale. Results: 17 patients with pelvic tumors were included, 10 (58.8%) primary bone sarcomas, 3 (17.6%) soft tissue sarcomas, 3 (17.6%) benign bone tumors, 1 (5.8%) neoplasia of hematological origin. Average follow-up of 30 ± 14. Most frequent surgical complication, surgical wound seroma, 6 patients (37.5%). Conclusions: A multidisciplinary team is required to individualize treatment with the best sequence of options, giving improvement in oncological and functional results.
Indexed as
Identifiers
39508806PMC12133224What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.